Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/188886
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRizzello, Loris-
dc.contributor.authorDe Matteis, Valeria-
dc.date.accessioned2022-09-12T09:45:03Z-
dc.date.available2022-09-12T09:45:03Z-
dc.date.issued2022-07-07-
dc.identifier.issn1667-5746-
dc.identifier.urihttp://hdl.handle.net/2445/188886-
dc.description.abstractThe SARS-CoV-2 outbreaks highlighted the need for effective, reliable, fast, easy-to-do and cheap diagnostics procedures. We pragmatically experienced that an early positive-case detection, inevitably coupled with a mass vaccination campaign, is a milestone to control the COVID-19 pandemic. Gold nanoparticles (AuNPs) can indeed play a crucial role in this context, as their physicochemical, optics and electronics properties are being extensively used in photothermal therapy (PTT), radiation therapy (RT), drug delivery and diagnostic. AuNPs can be synthesized by several approaches to obtain different sizes and shapes that can be easily functionalized with many kinds of molecules such as antibodies, proteins, probes, and lipids. In addition, AuNPs showed high biocompatibility making them useful tool in medicine field. We thus reviewed here the most relevant evidence on AuNPs as effective way to detect the presence of SARS-CoV-2 antigens. We trust future diagnostic efforts must take this 'old-fashioned' nanotechnology tool into consideration for the development and commercialization of reliable and feasible detection kits.-
dc.format.extent11-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.32604/biocell.2022.021059-
dc.relation.ispartofBiocell, 2022, vol. 46, num. 11, p. 2369-2380-
dc.relation.urihttps://doi.org/10.32604/biocell.2022.021059-
dc.rightscc by (c) Rizzello, Loris et al., 2022-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))-
dc.subject.classificationSARS-CoV-2-
dc.subject.classificationNanopartícules-
dc.subject.otherSARS-CoV-2-
dc.subject.otherNanoparticles-
dc.titleIdentification of SARS-CoV-2 by Gold Nanoparticles-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2022-09-12T08:34:47Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina6553089-
Appears in Collections:Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))

Files in This Item:
File Description SizeFormat 
2022_Biocell_Identification_RizzelloL.pdf4.3 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons